Hypertension Management: Rationale for Triple Therapy Based on Mechanisms of Action

Executive Summary: Heart Disease and Stroke Statistics—2012 Update

(2012) et al.   CIRCULATION

Renin-Angiotensin-Aldosterone Blockade for Cardiovascular Disease Prevention

(2011) Krishnaswami Vijayaraghavan et al.   CARDIOLOGY CLINICS

Is blood pressure control to less than 140/less than 90 mmHg in 50% of all hypertensive patients as good as we can do in the USA: or is this as good as it gets?

(2011) Brent M Egan et al.   CURRENT OPINION IN CARDIOLOGY

Low Medication Adherence and the Incidence of Stroke Symptoms Among Individuals With Hypertension: The REGARDS Study

(2011) Paul Muntner et al.   Journal of Clinical Hypertension

A Titrate-to-Goal Study of Switching Patients Uncontrolled on Antihypertensive Monotherapy to Fixed-Dose Combinations of Amlodipine and Olmesartan Medoxomil ± Hydrochlorothiazide

(2011) Matthew R. Weir et al.   Journal of Clinical Hypertension

Physician attitudes to blood pressure control

(2011) Josep Redon et al.   JOURNAL OF HYPERTENSION

Aliskiren and the calcium channel blocker amlodipine combination as an initial treatment strategy for hypertension control (ACCELERATE): a randomised, parallel-group trial

(2011) Morris J Brown et al.   LANCET

Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status

(2010) Terry KW Ma et al.   BRITISH JOURNAL OF PHARMACOLOGY

Pathogenesis and Clinical Physiology of Hypertension

(2010) Mukesh Singh et al.   CARDIOLOGY CLINICS

Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study

(2010) Suzanne Oparil et al.   CLINICAL THERAPEUTICS

Vascular Effects of Antihypertensive Drug Therapy

(2010) Asia Rehman et al.   CURRENT HYPERTENSION REPORTS

Long-term safety and efficacy of aliskiren and valsartan combination with or without the addition of HCT in patients with hypertension

(2010) Steven G. Chrysant et al.   CURRENT MEDICAL RESEARCH AND OPINION

Adherence and persistence of single-pill ARB/CCB combination therapy compared to multiple-pill ARB/CCB regimens

(2010) F. Zeng et al.   CURRENT MEDICAL RESEARCH AND OPINION

Evaluation of compliance and health care utilization in patients treated with single pill vs. free combination antihypertensives

(2010) Weiyi Yang et al.   CURRENT MEDICAL RESEARCH AND OPINION

Optimal Antagonism of the Renin-Angiotensin-Aldosterone System

(2010) Christian Werner et al.   DRUGS

Rationale for Triple-Combination Therapy for Management of High Blood Pressure

(2010) Alan H. Gradman   Journal of Clinical Hypertension

Factors associated with therapeutic inertia in hypertension: validation of a predictive model

(2010) Josep Redón et al.   JOURNAL OF HYPERTENSION

Combination therapy in hypertension

(2010) Alan H. Gradman et al.   Journal of the American Society of Hypertension

Adherence to Treatment Guidelines and Therapeutic Regimens: A US Claims-Based Benchmark of a Commercial Population

(2010) C. Ron Cantrell et al.   Population Health Management

Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 Trials

(2009) David S. Wald et al.   AMERICAN JOURNAL OF MEDICINE

Triple Antihypertensive Therapy With Amlodipine, Valsartan, and Hydrochlorothiazide

(2009) David A. Calhoun et al.   HYPERTENSION

Triple Fixed-Dose Combination Therapy

(2009) Henry R. Black   HYPERTENSION

Compliance, Safety, and Effectiveness of Fixed-Dose Combinations of Antihypertensive Agents

(2009) Ajay K. Gupta et al.   HYPERTENSION

Clinical Inertia and Blood Pressure Goal Attainment

(2009) Jan Basile   Journal of Clinical Hypertension

Pathogenesis of essential hypertension: historical paradigms and modern insights

(2009) Richard J Johnson et al.   JOURNAL OF HYPERTENSION

Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document

(2009) Giuseppe Mancia et al.   JOURNAL OF HYPERTENSION

Angiotensin Receptor Blocker and Dihydropyridine Calcium Channel Blocker Combinations: An Emerging Strategy in Hypertension Therapy

(2009) Suzanne Oparil et al.   POSTGRADUATE MEDICINE

Pathophysiology of Hypertension

(2008) Katherine Heilpern   ANNALS OF EMERGENCY MEDICINE

When More Is Not Better

(2008) Michele Heisler et al.   CIRCULATION

Efficacy and Tolerability of Olmesartan Medoxomil Combined with Amlodipine in Patients with Moderate to Severe Hypertension after Amlodipine Monotherapy

(2008) Massimo Volpe et al.   CLINICAL DRUG INVESTIGATION

The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study

(2008) Steven G. Chrysant et al.   CLINICAL THERAPEUTICS

Assessment of adherence, persistence, and costs among valsartan and hydrochlorothiazide retrospective cohorts in free-and fixed-dose combinations

(2008) Diana I. Brixner et al.   CURRENT MEDICAL RESEARCH AND OPINION

Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients

(2008) Kenneth Jamerson et al.   NEW ENGLAND JOURNAL OF MEDICINE